Follow-The-Filings

Security · featured owners

FATE Fate Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.3%
  • $1M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Nathan Fischel - Dafna Ca...) · not free-float ownership

  1. Nathan Fischel reduce 0.27%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.27% Reduce −4.5% 525,000 $1M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q 10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q 10-Q Filing Doc
DEFA14A DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K 10-K Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q 10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,2.05,9.01 Filing Doc
10-Q 10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 25 shown

Filed Form Detail Links
4 Period Aug 4, 2026 · 2 forms Filing Doc
4 Period Jun 12, 2026 · 9 forms Filing Doc
4 Period May 20, 2026 · 2 forms Filing Doc
4 Period May 6, 2026 Filing Doc
4 Period May 5, 2026 · 2 forms Filing Doc
4/A Period Apr 20, 2026 Filing Doc
4 Period Apr 20, 2026 Filing Doc
4 Period Jan 15, 2026 · 3 forms Filing Doc
4 Period Jan 9, 2026 · 2 forms Filing Doc
4 Period Oct 20, 2025 Filing Doc
4 Period Aug 4, 2025 Filing Doc

Updated 7 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $63.53M $13.63M $6.65M
Net income -$160.93M -$186.26M -$136.32M
Net margin * -253.3% -1366.5% -2051.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $331.54M $291.91M $208.7M
Total non-current assets * $174.68M $148.78M $110.23M
Total assets $506.22M $440.69M $318.94M
Total current liabilities $39.09M $38.52M $36.07M
Total equity $368.42M $318.73M $207.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$132.26M -$122.87M -$106.08M
Cash from investing $112.66M $12.22M $111.17M
Cash from financing $85,000 $99.89M $5.49M
Net change in cash -$19.51M -$10.76M $10.57M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders